Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2236162 | 0.89 | PPARD (0.42) | PPARDTSHRMEN1GAACYP2C9 | |
| SCHEMBL2234140 | 0.89 | PPARD (0.42) | PPARDTSHRMEN1GAACYP2C9 | |
| SCHEMBL2234247 | 0.86 | PPARD (0.47) | PPARDTSHRMEN1GAACYP2C9 | |
| SCHEMBL2235786 | 0.85 | — | — | |
| SCHEMBL14782075 | 0.82 | MEN1 (0.50) | PPARDTSHRMEN1GAACYP2C9 | |
| SCHEMBL2234204 | 0.80 | PPARD (0.41) | PPARDTSHRMEN1GAACYP2C9 | |
| SCHEMBL19316395 | 0.79 | PPARD (0.52) | PPARDTSHRTDP1TP53 | |
| SCHEMBL9003229 | 0.79 | PPARD (0.52) | PPARDTSHRMEN1GAACYP2C9 | |
| SCHEMBL2235703 | 0.79 | PPARD (0.44) | PPARDTSHRMEN1GAACYP2C9 | |
| SCHEMBL4164665 | 0.79 | PPARD (0.56) | PPARDTSHRMEN1GAACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8182789-B2 | Intermediate compound of technetium nitride complex for radiodiagnostic imaging | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2012-05-22 | — | — | US | disclosed |
| US-8182789-B2 | Intermediate compound of technetium nitride complex for radiodiagnostic imaging | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2012-05-22 | — | — | US | disclosed |
| EP-1973923-B1 | INTERMEDIATE COMPOUND OF TECHNETIUM NITRIDE COMPLEX FOR RADIODIAGNOSTIC IMAGING | NIHON MEDIPHYSICS CO LTD (JP) | 2011-08-17 | — | — | EP | disclosed |
| US-20100160615-A1 | INTERMEDIATE COMPOUND OF TECHNETIUM NITRIDE COMPLEX FOR RADIODIAGNOSTIC IMAGING | NIHON MED-PHYSICS CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20100160615-A1 | INTERMEDIATE COMPOUND OF TECHNETIUM NITRIDE COMPLEX FOR RADIODIAGNOSTIC IMAGING | NIHON MED-PHYSICS CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| EP-1973923-A1 | INTERMEDIATE COMPOUND OF TECHNETIUM NITRIDE COMPLEX FOR RADIODIAGNOSTIC IMAGING | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2008-10-01 | — | — | EP | disclosed |
| US-20080124273-A1 | Novel cationic metal complex radiopharmaceuticals | PURDUE RESEARCH FOUNDATION | 2008-05-29 | — | — | US | disclosed |
| WO-2007083395-A1 | INTERMEDIATE COMPOUND OF TECHNETIUM NITRIDE COMPLEX FOR RADIODIAGNOSTIC IMAGING | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2007-07-26 | — | — | WO | disclosed |
| WO-2006080993-A1 | NOVEL CATIONIC METAL COMPLEX RADIOPHARMACEUTICALS | PURDUE RESEARCH FOUNDATION (US) | 2006-08-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080124273-A1 | Novel cationic metal complex radiopharmaceuticals | SLC39A14, CLTC, TMEM165 | PPARD 1067/4885TSHR 100/4885MEN1 56/4885 |
| US-20100160615-A1 | INTERMEDIATE COMPOUND OF TECHNETIUM NITRIDE COMPLEX FOR RADIODIAGNOSTIC IMAGING | MEN1, NCDN, C1R | PPARD 2640/4885TSHR 33/4885MEN1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.